InvestorsHub Logo

Whalatane

11/18/18 6:09 PM

#160824 RE: Jt0082 #160805

Jt. Thx for posting that link
Sold my small position in MDGL as soon as I saw the VKTX data .
Doubt if MDGL really pursues the He FH market as their drug only lowered LDL by around 21%

I tend to think that the R-It data really crimps the potential for extra LDL lowering drugs ...ESPR ,MDGL etc .... and really shifts the focus away from only LDL .
For the few Cardiologists I know ... it’s all about MOA at present .... how is Vascepa actually working
Kiwi